Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Addition of Daclizumab to Standard Graft-Versus-Host Disease Prophylaxis in Patients with Thalassemia Major Undergoing Transplantation from Alternative Donor Hematopoietic Stem-Cell Transplantation: A Single-Center Retrospective Analysis from China

Blood (2024) 144 (Supplement 1): 2152.

https://doi.org/10.1182/blood-2024-205021

Published: 2024

Journal Articles

Using T-Lymphocyte Subsets at Engraftment to Predict the Risk of Acute Graft Versus Host Disease in Patients with Thalassemia Major：Development of a New Predictive Nomogram

Hongwen Xiao, Gaohui Yang, Qiuling Huang, Zhenbin Wei, Zhaoping Gan, Meiqing Wu, Zeyan Shi, Huicheng Huang, Zhaofang Pan, Lianjin Liu, Lingling Shi, Zhongming Zhang, Qifa Liu, Rongrong Liu, Yongrong Lai

Blood (2024) 144 (Supplement 1): 2139.

https://doi.org/10.1182/blood-2024-205258

Published: 2024

Journal Articles

The Optimal Dose of Anti-Thymocyte Globulin in Beta-Thalassemia Major Following Matched Sibling Donor Hematopoietic Stem Cell Transplantation: A Single-Center, Open-Label, Randomized, Controlled Clinical Study

Qiuling Huang, Rongrong Liu, Lianjin Liu, Meiqing Wu, Lingling Shi, Gaohui Yang, Zhongming Zhang, Qifa Liu, Yongrong Lai

Blood (2024) 144 (Supplement 1): 2134.

https://doi.org/10.1182/blood-2024-205204

Published: 2024

Journal Articles

Invasive Fungal Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation in China: A Multicenter Epidemiological Study (CAESAR 2.0)

Chuan Li, Danping Zhu, Jia Chen, Xiaoyu Zhu, Nainong Li, Weijie Cao, Zhongming Zhang, Yehui Tan, Xiaoxia Hu, Hailong Yuan, Xiaosheng Fang, Yue Yin, Hongtao Wang, Nan Li, Xiao Jun Huang, Yuqian Sun

Blood (2024) 144 (Supplement 1): 2133.

https://doi.org/10.1182/blood-2024-202020

Published: 2024

Journal Articles

A Multi-Center Clinical Trial of Allogeneic Hematopoietic Stem Cell Transplants in Transfusion Dependent Thalassemia

Blood (2024) 144 (Supplement 1): 378.

https://doi.org/10.1182/blood-2024-204984

Published: 2024

Journal Articles

Changing Donor Was Critical for the Successful Salvage Second Transplantation for Graft Failure after the First Allogeneic Stem Cell Transplantation: A Chinese Multicenter Retrospective Study

Blood (2024) 144 (Supplement 1): 2109.

https://doi.org/10.1182/blood-2024-205561

Published: 2024

Journal Articles

Addition of Daclizumab to Standard Graft-Versus-Host Disease Prophylaxis in Patients with Thalassemia Major Undergoing Transplantation from Related Haploidentical Donor and Unrelated Donor Hematopoietic Stem-Cell Transplantation: A Single-Center Retrospective Analysis from China

Rongrong Liu, Gaohui Yang, Lingling Shi, Lianjin Liu, Zhongming Zhang, Cuifeng Huang, Zhenbin Wei, Beicai Liu, Zhaoping Gan, Wenqiang Xie, Rui Huang, Na Sun, Shuyi Wei, Xuemei Zhou, Yinghua Chen, Yanye Liu, Zhi Li, Qifa Liu, Yongrong Lai

Blood (2023) 142 (Supplement 1): 5252.

https://doi.org/10.1182/blood-2023-180056

Published: 2023

Journal Articles

Impact of COVID-19 in Thalassemia Patients Undergoing Hematopoietic Stem Cell Transplant Recipients

Shao Jingxuan, Rongrong Liu, Yongrong Lai, Xinmei Wei, Ning Zhang, Cuifeng Huang, Qifa Liu, Zhongming Zhang, Gaohui Yang, Zhenbin Wei, Lianjin Liu

Blood (2023) 142 (Supplement 1): 7114.

https://doi.org/10.1182/blood-2023-180570

Published: 2023

Journal Articles

Letermovir Prophylaxis for Cytomegalovirus Reactivation in β Thalassemia Major Children after Hematopoietic Cell Transplantation

Lingling Shi, Rongrong Liu, Zhongming Zhang, Cuifeng Huang, Lianjin Liu, Yibin Yao, Zhenbin Wei, Shuyi Wei, Zhaoping Gan, Na Sun, Beicai Liu, Rui Huang, Xuemei Zhou, Yinghua Chen, Qifa Liu, Yongrong Lai

Blood (2023) 142 (Supplement 1): 7053.

https://doi.org/10.1182/blood-2023-189043

Published: 2023

Journal Articles

Basiliximab in the Prevention of aGVHD for Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients with Thalassemia Major: A Prospective, Multicenter, Open-Label, Randomized Controlled Study

Rongrong Liu, Meiqing Wu, Qiaochuan Li, Lianjin Liu, Chunjie Qin, Hong Chen, Lingling Shi, Gaohui Yang, Zeyan Shi, Zhongqing Li, Zhenbin Wei, Beicai Liu, Jing Fan, Yinghua Chen, Xuemei Zhou, Zhongming Zhang, Yongrong Lai, Qifa Liu

Blood (2022) 140 (Supplement 1): 1383–1384.

https://doi.org/10.1182/blood-2022-166003

Published: 2022

Journal Articles

Idarubicin Intensified Bucy Regimen in Allogeneic Peripheral Blood Stem Cell Transplantation for High-Risk Acute Myeloid Leukemia: A Multicenter, Randomized Study (NCT 01766375)

Qiaochuan Li, Meiqing Wu, Zhongming Zhang, Lianjin Liu, Lingling Shi, Qifa Liu, Yongrong Lai

Blood (2017) 130 (Supplement 1): 597.

https://doi.org/10.1182/blood.V130.Suppl_1.597.597

Published: 2017

Journal Articles

Unrelated Donor Peripheral Blood Stem Cell Transplantation for Thalassaemia: A Single Institution Experience of 53 Patients

Qiaochuan Li, Meiqing Wu, Zhongming Zhang, Lianjin Liu, Yongrong Lai

Blood (2017) 130 (Supplement 1): 357.

https://doi.org/10.1182/blood.V130.Suppl_1.357.357

Published: 2017

NARROW

Addition of Daclizumab to Standard Graft-Versus-Host Disease Prophylaxis in Patients with Thalassemia Major Undergoing Transplantation from Alternative Donor Hematopoietic Stem-Cell Transplantation: A Single-Center Retrospective Analysis from China

Using T-Lymphocyte Subsets at Engraftment to Predict the Risk of Acute Graft Versus Host Disease in Patients with Thalassemia Major：Development of a New Predictive Nomogram

The Optimal Dose of Anti-Thymocyte Globulin in Beta-Thalassemia Major Following Matched Sibling Donor Hematopoietic Stem Cell Transplantation: A Single-Center, Open-Label, Randomized, Controlled Clinical Study

Invasive Fungal Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation in China: A Multicenter Epidemiological Study (CAESAR 2.0)

A Multi-Center Clinical Trial of Allogeneic Hematopoietic Stem Cell Transplants in Transfusion Dependent Thalassemia

Changing Donor Was Critical for the Successful Salvage Second Transplantation for Graft Failure after the First Allogeneic Stem Cell Transplantation: A Chinese Multicenter Retrospective Study

Addition of Daclizumab to Standard Graft-Versus-Host Disease Prophylaxis in Patients with Thalassemia Major Undergoing Transplantation from Related Haploidentical Donor and Unrelated Donor Hematopoietic Stem-Cell Transplantation: A Single-Center Retrospective Analysis from China

Impact of COVID-19 in Thalassemia Patients Undergoing Hematopoietic Stem Cell Transplant Recipients

Letermovir Prophylaxis for Cytomegalovirus Reactivation in β Thalassemia Major Children after Hematopoietic Cell Transplantation

Basiliximab in the Prevention of aGVHD for Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients with Thalassemia Major: A Prospective, Multicenter, Open-Label, Randomized Controlled Study

Idarubicin Intensified Bucy Regimen in Allogeneic Peripheral Blood Stem Cell Transplantation for High-Risk Acute Myeloid Leukemia: A Multicenter, Randomized Study (NCT 01766375)

Unrelated Donor Peripheral Blood Stem Cell Transplantation for Thalassaemia: A Single Institution Experience of 53 Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only